Staying informed and checking in: Make use of any program resources
For prediabetes patients, this testing enables personalized dosing strategies and helps identify whether you may benefit from the Microdose Protocol ($129/mo) or a standard-dose approach, optimizing results from the start
Large platforms like Ro will acquire smaller, niche players to broaden their service offerings, while traditional healthcare systems will buy or build their own telehealth capabilities to compete, leading to a market dominated by a few large, integrated players
How it helps disc herniation specifically: Upregulates tendon-related growth factors BPC-157 activates the Egr-1 transcription factor, which drives collagen synthesis in fibrous tissue including the annulus fibrosus Promotes angiogenesis increases VEGF expression, improving blood supply to the avascular disc environment Neuroprotective effects multiple rodent studies show BPC-157 accelerates peripheral nerve regeneration and protects against nerve compression injury Systemic anti-inflammatory suppresses pro-inflammatory cytokine cascades without the immunosuppressive side effects of steroids Protocol: Dose: 250500mcg/day subcutaneous injection Injection site: Lower abdomen or closest accessible subQ site to the injury (though systemic distribution means proximity matters less than for localized joint issues) Duration: 68 weeks loading phase, reassess at week 8 Most people notice reduced nerve pain and improved mobility within 24 weeks
Cold sensations have been reported anecdotally by some trial participants, but precise incidence figures are not available from published Phase 2 data
Weight Loss: The combination of reduced calorie intake, prolonged feelings of fullness, and better blood sugar control typically results in weight loss for individuals using GLP-1s
